Delivery Order SPE2DB22D3011-SPE2DB25FQ2SM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,599.67 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.99 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5ML) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a non-competed procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $4,429.98 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $8,212.02, with a completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.68 to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with an ultimate completion date of August 14, 2025. The award was made on August 13, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a $28,225.08 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,696.28 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Rotarix vaccine oral syringes in 1.5ml quantities. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract issued under...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2SMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,433.68 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe 1.5mL formulation, with a completion date of September 15, 2025. This is a firm fixed-price, non-set-aside contract issued on September 12, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio demonstrates its capability to supply a diverse range of pharmaceutical products, vaccines, and medical devices through competitive award processes. This particular order for Rotarix vaccine represents routine medical supply procurement within the company's broader role as a pharmaceutical prime vendor supporting military readiness and healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/12/25 |